Healthcare entity
All 1 tracked stories fall under one category: regulation. Of the tracked stories, 1 of 1 also mention CDC National Center for Injury Prevention and Control, the most common co-covered peer. At 5, the average consequence score sits below the same-window beat average of 5.9.
Last mentioned: Aug 7, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: regulation. Of the tracked stories, 1 of 1 also mention CDC National Center for Injury Prevention and Control, the most common co-covered peer. At 5, the average consequence score sits below the same-window beat average of 5.9. Source depth averages 2 original sources per story, versus 2.1 across the same-window beat baseline. We currently track 1 Healthcare story that mention Cannabis Hyperemesis Syndrome, all published on August 7, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 20 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Cannabis Hyperemesis Syndrome. Shared-story counts are live from our verified record — not editorial picks.
The introduction of a dedicated ICD-10 code for cannabis hyperemesis syndrome triggered a 16% jump in emergency department diagnoses, unmasking a massive hidden burden on U.S. hospitals. With 200,000 prior ED visits and 2.75 million annual sufferers, health systems must now manage increased demand, train clinicians, and integrate the new code into EHRs and population health analytics.
Cannabis Hyperemesis Syndrome is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
